OBJECTIVES: This paper aims to review the evidence to support the effectiveness of sympathectomy as a treatment for @entity2652 in terms of relief of @entity2652 , @entity1 satisfaction, recurrence of blushing, @entity1 regretting treatment and its associated complications. METHODS: A systematic search strategy was performed in Ovid-Medline, Embase, Cochrane library and NICE. Studies reporting outcomes of sympathetic interruption in the treatment of @entity2652 were retrieved. RESULTS: Nine studies met the inclusion criteria with 1369 @entity1 included in the final analysis. The age range of @entity1 was 8 to 74  years (from 7 studies) with 56% females. Mean follow up was 21  months in 8 studies (range 6 to 30  months). The pooled proportion of @entity1 who had good relief of @entity2652 was 78.30% (95% C.I. 58.20% - 98.39%). Complete satisfaction was reported in 84.02% (95% C.I. 71.71% - 96.33%). @entity3190 and @entity8810 were the commonest complications occurring in 74.18% (95% C.I. 58.10% - 90.26%) and 24.42% (95% C.I. 12.22% - 36.61%) respectively. The estimated proportion of @entity1 regretting surgery was 6.79% (C.I 2.08% 11.50%). CONCLUSION: Sympathetic interruption at T2 or T2-3 ganglia appears to be an effective treatment for @entity2652 . However, lack of randomized trials comparing sympathetic interruption with non-surgical methods of treatment and heterogeneity of included studies with respect to assessment of outcome measures preclude strong evidence and definitive recommendations.

Role of surgical thoracic sympathetic interruption in treatment of XXXX : A systematic review.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity8810 :: ('MESH:D013547', 'Disease') :: ['gustatory sweating'] @entity3190 :: ('MESH:D006946', 'Disease') :: ['Compensatory sweating'] @entity2652 :: ('MESH:D005148', 'Disease') :: ['facial blushing']
@entity2652 :: (MESH:D005148,Disease) :: ['facial blushing']
